SCHEMBL29746473

SCHEMBL29746473

O=C1Cc2cc(-c3ccc4cc(Cl)ccc4n3)ccc2N1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 2/20 0.58
▸ PGR P06401 3/20 0.56
▸ PDE3B Q13370 2/20 0.50
▸ PDE3A Q14432 2/20 0.50
▸ CMA1 P23946 1/20 0.48
▸ CYP1A2 P05177 1/20 0.45
▸ CYP11B1 P15538 1/20 0.45
▸ CYP11B2 P19099 1/20 0.45
▸ GRIA1 P42261 3/20 0.44
▸ CACNG8 Q8WXS5 3/20 0.44
▸ SCN9A Q15858 1/20 0.44
▸ MET P08581 1/20 0.43
▸ TDP2 O95551 1/20 0.43
▸ PDE4A P27815 1/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ PDE4C Q08493 1/20 0.42
▸ PDE4D Q08499 1/20 0.42
▸ BRD4 O60885 1/20 0.41
▸ MTOR P42345 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26613466 1.00 AHR (0.58) AHRPGRPDE3BPDE3ACMA1
SCHEMBL1900155 0.78 AHR (0.77) AHRPGRPDE3BPDE3ACMA1
SCHEMBL154614 0.76 AHR (1.00) AHRPGRPDE3BPDE3ACMA1
SCHEMBL29746115 0.74 MAPT (0.53) PDE3BPDE3ACYP1A2CYP11B1CYP11B2
SCHEMBL26613480 0.74 MAPT (0.58) PDE3BPDE3ACYP1A2CYP11B1CYP11B2
SCHEMBL26613471 0.74 MAPT (0.53) PDE3BPDE3ACYP1A2CYP11B1CYP11B2
SCHEMBL15682858 0.74 AHR (0.54) AHRPGRPDE3BPDE3ACMA1
SCHEMBL29746163 0.74 MAPT (0.58) PDE3BPDE3ACYP1A2CYP11B1CYP11B2
SCHEMBL18189562 0.73 AHR (0.69) AHRPGRPDE3BPDE3ACMA1
SCHEMBL3519711 0.73 PGR (1.00) AHRPGRPDE3BPDE3ACMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119403554-A Therapeutic or prophylactic agent for amyotrophic lateral sclerosis 东丽株式会社 2025-02-07 — — CN disclosed
CN-116648245-A Tetrahydroquinoline derivative and medical application thereof 东丽株式会社 2023-08-25 — — CN disclosed
WO-2022138888-A1 TETRAHYDROQUINOLINE DERIVATIVE AND MEDICINAL USE THEREOF 東レ株式会社 2022-06-30 — — WO disclosed
Send feedback